Thread: Preliminary results from Biogen's Phase 1 study of alpha synuclein & PD (BIIB054)
View Single Post
Old 04-18-2018, 09:58 PM
jeffreyn jeffreyn is offline
Member
  
Join Date: Apr 2016
Location: Australia
Posts: 352
8 yr Member
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
8 yr Member
Default Preliminary results from Biogen's Phase 1 study of alpha synuclein & PD (BIIB054)
"Preliminary results from the first study of BIIB054 in patients with [Parkinson's] shows a favorable [pharmacokinetics], safety and tolerability profiles, providing rationale for further clinical development,"

#AAN218 Biogen's BIIB54 Posts Positive Data in Parkinson's Trial
jeffreyn is offline   Reply With QuoteReply With Quote